The European Commission on Wednesday said it has given its conditional approval to U.S. medical device maker Abbott Laboratories’ (ABT.N) bid for peer St Jude Medical Inc (STJ.N).
Reuters reported on Nov. 15 that the $25 billion deal was going to be cleared in Brussels.
The European Commission, the mergers regulator, said in a statement that its approval was conditional on “Abbott divesting two devices used in cardiovascular treatments.”
(Reporting by Gabriela Baczynska)
